GLOBAL COUGH SYRUP MARKET 2023-2030

Lifesciences | Pharmaceuticals

GLOBAL COUGH SYRUP MARKET 2023-2030

Market by Product Type, Age Group, Distribution Channel, and Regional Outlook | Forecast 2023-2030

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Cough syrup refers to a medicinal liquid preparation engineered to address coughing and its associated symptoms. They are carefully formulated with a combination of pharmacologically active ingredients, such as antitussives, expectorants, antihistamines, and analgesics, to reduce irritation in the throat and airways, suppress cough reflexes, encourage mucus clearance, and manage pain. Moreover, they meet rigorous quality and regulatory requirements, making them a reliable option in the medical industry for treating respiratory conditions.

According to Triton Market Research’s report, the Global Cough Syrup Market is likely to grow with a CAGR of 3.64% over the forecast period 2023-2030. The market was valued at $5501.63 million in 2022 and is expected to reach a revenue of $7332.12 million by 2030.


Click here to check out our blog on the Global Cough Syrup Market

MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES

Several factors, such as the high incidence of respiratory ailments, the vulnerability of the geriatric population to respiratory diseases, and innovations in cough syrup formulations, drive the market. The incidence of respiratory diseases and infections is still a major contributor, particularly during the flu and cold seasons. An aging population that is more prone to respiratory illnesses further raises the demand for cough syrups. The consumer base is also growing because of a variety of formulations like the creation of sugar-free, herbal syrups and homeopathic and kid-friendly varieties. Another important factor is the easy availability of over-the-counter (OTC) medications online and at pharmacies. Additional factors driving the market include changing lifestyles, higher pollution levels, and environmental allergens.

The consumption of cough syrup has been greatly spurred by the rise in respiratory illnesses around the world. Due to factors including air pollution, smoking, and shifting weather patterns, illnesses like asthma, chronic obstructive pulmonary disease (COPD), and respiratory tract infections are becoming more common. According to the Global Impact of Respiratory Disease Report, COPD affects 200 million people globally and accounts for 3.2 million deaths annually, ranking it as the third greatest cause of mortality.

However, overdosage risks associated with cough syrups, strict regulatory procedures, and deaths due to the toxicity of ingredients used in cough syrups are all restraining the cough syrup market. Regulatory agencies have responded to cough syrup usage and recent reports of deaths linked to cough syrup overuse, resulting in the implementation of stricter processes within the market. These procedures are intended to reduce the likelihood of misuse, safeguard the public’s health, and respond to growing worries about the improper use of cough syrups comprising potentially dangerous components.

Nevertheless, increasing demand for sugar-free cough syrups is expected to create lucrative opportunities for the market. The prevalence of diabetes has been rising more rapidly in low- and middle-income countries than in high-income countries. People with diabetes are at increased risk of being infected with the cold or flu virus. In this regard, keeping blood sugars in control has been a challenge among diabetic patients since traditional cough syrups include sugar. Hence, artificial sweeteners are being used in cough syrups, also called sugar substitutes, low-calorie sweeteners, or nonnutritive sweeteners.



Report scope can be customized per your requirements - Request Free Sample Report 

KEY GEOGRAPHIES COVERED:

•         North America: United States and Canada

•         Europe: United Kingdom, France, Germany, Spain, Italy, and Rest of Europe

•         Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia-Pacific

•         Latin America: Brazil, Mexico, and Rest of Latin America

•         Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa, and Rest of Middle East & Africa

SEGMENTATION ANALYSIS – COUGH SYRUP MARKET:

•         Market by Product Type:

            o        Cough Suppressants

            o        Combination Medicines

            o        Expectorants

Combination medicines are estimated to progress with the highest CAGR during the forecast period. Combination medicines in cough syrups refer to formulations that contain a mix of active ingredients targeting different aspects of respiratory symptoms. These medicines often combine expectorants, cough suppressants, antihistamines, decongestants, and sometimes even pain relievers or fever reducers. The demand for combination medicines in the market is increasing for several reasons, including the desire for convenience and all-in-one solutions. When individuals experience a combination of symptoms such as cough, congestion, sore throat, and mild pain, they prefer to address them simultaneously rather than taking multiple separate medications.

•         Market by Age Group:

            o        Adults

            o        Adolescents

            o        Pediatric

•         Market by Distribution Channel:

            o        Retail Pharmacies

            o        Hospital Pharmacies

            o        E-Pharmacies

Retail Pharmacies lead the market in terms of revenue. They offer a wide selection of cough syrups, providing consumers with various options to address specific needs. These pharmacies typically stock both prescription and over-the-counter (OTC) cough syrups. Moreover, these establishments are often strategically located in neighborhoods and commercial areas, making them easily accessible to consumers.

COMPETITIVE LANDSCAPE:

The cough syrup market by company profile helps dive into data about the key players in this industry. The strategic initiatives for each of the companies considered have been covered in detail.

Acquisition (April 2021): Pfizer Inc

Pfizer Inc purchased Amplyx Pharmaceuticals Inc to expand its product line in life-threatening diseases that affect immune systems.

Divestiture (April 2023): Glenmark Pharma

Glenmark Pharma announced its plan to sell the majority of its 82% ownership in Glenmark Life Sciences in order to lower its debt.

 

KEY BENEFITS OF THE REPORT:

·       Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.

·       Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.

·       The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.

·       The scope of the market report comprises the current scenario of the global cough syrup market, along with the detailed overview of the industry outlook, market dynamics, segmentation analysis, regional outlook, and competitive landscape for the period 2023-2030.

 

FAQs:

Q 1) What are the natural or herbal alternatives to traditional cough syrups?

There are herbal and natural treatments for mild coughs, including tinctures made from herbs, ginger tea, and honey-based syrups. These alternatives are becoming more popular as a result of their alleged safety and lack of negative side effects.

Q 2) What dietary limitations or safety measures should be observed during cough syrup consumption?

Alcohol should not be consumed when using cough syrups since it can worsen the sleepiness brought by certain cough syrups. Additionally, it’s crucial to adhere to the directions on the product label and get medical advice in case of dietary restrictions or certain medical conditions.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. GLOBAL COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE COUGH SYRUP MARKET

2.1.1. COVID-19 IMPACT

2.1.2. UKRAINE-RUSSIA WAR IMPACT

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTES

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. THREAT OF COMPETITIVE RIVALRY

2.3. MARKET MATURITY ANALYSIS

2.4. INDUSTRY COMPONENTS

2.4.1. RAW MATERIALS

2.4.2. MANUFACTURERS

2.4.3. DISTRIBUTORS

2.4.4. RETAILERS

2.5. REGULATORY FRAMEWORK

2.6. KEY MARKET STRATEGIES

2.6.1. COLLABORATIONS

2.6.2. PRODUCT LAUNCHES

2.6.3. ACQUISITIONS

2.6.4. BUSINESS DIVESTITURES & EXPANSIONS

2.7. MARKET DRIVERS

2.7.1. HIGH INCIDENCE OF RESPIRATORY AILMENTS

2.7.2. VULNERABILITY TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION

2.7.3. INNOVATIONS IN COUGH SYRUPS

2.8. MARKET CHALLENGES

2.8.1. OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUPS

2.8.2. STRICT REGULATORY REQUIREMENTS

2.8.3. INCREASING COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS

2.9. MARKET OPPORTUNITIES

2.9.1. SELF-MEDICATION TRENDS INCREASE DEMAND FOR OTC DRUGS

2.9.2. HERBAL COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE

2.9.3. EASE OF PURCHASE OFFERED BY E-COMMERCE CHANNELS

2.9.4. AVAILABILITY OF SUGAR-FREE COUGH SYRUPS

2.9.5. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.10. ANALYST PERSPECTIVE

3. GLOBAL COUGH SYRUP MARKET – BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS

3.2. COMBINATION MEDICINES

3.3. EXPECTORANTS

4. GLOBAL COUGH SYRUP MARKET – BY AGE GROUP

4.1. ADULTS

4.2. ADOLESCENTS

4.3. PEDIATRIC

5. GLOBAL COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACIES

5.2. HOSPITAL PHARMACIES

5.3. E-PHARMACIES

6. GLOBAL COUGH SYRUP MARKET – BY REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1. MARKET BY PRODUCT TYPE

6.1.2. MARKET BY AGE GROUP

6.1.3. MARKET BY DISTRIBUTION CHANNEL

6.1.4. COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.1.1. UNITED STATES COUGH SYRUP MARKET FORECAST & PROSPECTS

6.1.4.2. CANADA

6.1.4.2.1. CANADA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2. EUROPE

6.2.1. MARKET BY PRODUCT TYPE

6.2.2. MARKET BY AGE GROUP

6.2.3. MARKET BY DISTRIBUTION CHANNEL

6.2.4. COUNTRY ANALYSIS

6.2.4.1. UNITED KINGDOM

6.2.4.1.1. UNITED KINGDOM COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2.4.2. GERMANY

6.2.4.2.1. GERMANY COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2.4.3. FRANCE

6.2.4.3.1. FRANCE COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2.4.4. ITALY

6.2.4.4.1. ITALY COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2.4.5. SPAIN

6.2.4.5.1. SPAIN COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2.4.6. REST OF EUROPE

6.2.4.6.1. REST OF EUROPE COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3. ASIA-PACIFIC

6.3.1. MARKET BY PRODUCT TYPE

6.3.2. MARKET BY AGE GROUP

6.3.3. MARKET BY DISTRIBUTION CHANNEL

6.3.4. COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.1.1. CHINA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3.4.2. JAPAN

6.3.4.2.1. JAPAN COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3.4.3. INDIA

6.3.4.3.1. INDIA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3.4.4. SOUTH KOREA

6.3.4.4.1. SOUTH KOREA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3.4.5. ASEAN COUNTRIES

6.3.4.5.1. ASEAN COUNTRIES COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3.4.6. AUSTRALIA & NEW ZEALAND

6.3.4.6.1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET FORECAST & PROSPECTS

6.3.4.7. REST OF ASIA-PACIFIC

6.3.4.7.1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET FORECAST & PROSPECTS

6.4. LATIN AMERICA

6.4.1. MARKET BY PRODUCT TYPE

6.4.2. MARKET BY AGE GROUP

6.4.3. MARKET BY DISTRIBUTION CHANNEL

6.4.4. COUNTRY ANALYSIS

6.4.4.1. BRAZIL

6.4.4.1.1. BRAZIL COUGH SYRUP MARKET FORECAST & PROSPECTS

6.4.4.2. MEXICO

6.4.4.2.1. MEXICO COUGH SYRUP MARKET FORECAST & PROSPECTS

6.4.4.3. REST OF LATIN AMERICA

6.4.4.3.1. REST OF LATIN AMERICA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5. MIDDLE EAST AND AFRICA

6.5.1. MARKET BY PRODUCT TYPE

6.5.2. MARKET BY AGE GROUP

6.5.3. MARKET BY DISTRIBUTION CHANNEL

6.5.4. COUNTRY ANALYSIS

6.5.4.1. UNITED ARAB EMIRATES

6.5.4.1.1. UNITED ARAB EMIRATES COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5.4.2. TURKEY

6.5.4.2.1. TURKEY COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5.4.3. SAUDI ARABIA

6.5.4.3.1. SAUDI ARABIA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5.4.4. SOUTH AFRICA

6.5.4.4.1. SOUTH AFRICA COUGH SYRUP MARKET FORECAST & PROSPECTS

6.5.4.5. REST OF MIDDLE EAST & AFRICA

6.5.4.5.1. REST OF MIDDLE EAST & AFRICA COUGH SYRUP MARKET FORECAST & PROSPECTS

7. COMPETITIVE LANDSCAPE

7.1. GSK PLC

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY STRENGTHS

7.1.4. KEY CHALLENGES

7.2. PFIZER INC

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY STRENGTHS

7.2.4. KEY CHALLENGES

7.3. NOVARTIS AG

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY STRENGTHS

7.3.4. KEY CHALLENGES

7.4. RECKITT BENCKISER GROUP PLC

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY STRENGTHS

7.4.4. KEY CHALLENGES

7.5. THE PROCTER & GAMBLE COMPANY

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY STRENGTHS

7.5.4. KEY CHALLENGES

7.6. SANOFI SA

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY STRENGTHS

7.6.4. KEY CHALLENGES

7.7. CIPLA LIMITED

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY STRENGTHS

7.7.4. KEY CHALLENGES

7.8. KENVUE INC

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY STRENGTHS

7.8.4. KEY CHALLENGES

7.9. ASTRAZENECA PLC

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY STRENGTHS

7.9.4. KEY CHALLENGES

7.10. ACELLA PHARMACEUTICALS LLC

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY STRENGTHS

7.10.4. KEY CHALLENGES

7.11. THE HIMALAYA WELLNESS COMPANY

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY STRENGTHS

7.11.4. KEY CHALLENGES

7.12. MERCK KGAA

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY STRENGTHS

7.12.4. KEY CHALLENGES

7.13. ABBOTT LABORATORIES

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY STRENGTHS

7.13.4. KEY CHALLENGES

7.14. GLENMARK PHARMACEUTICALS LIMITED

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY STRENGTHS

7.14.4. KEY CHALLENGES

7.15. DABUR INDIA LTD

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY STRENGTHS

7.15.4. KEY CHALLENGES

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: GLOBAL COUGH SYRUP MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 7: GLOBAL COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 8: GLOBAL COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 9: GLOBAL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 10: GLOBAL COUGH SYRUP MARKET, BY REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 11: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 12: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 13: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 14: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 15: EUROPE COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 16: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 17: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 18: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 19: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 20: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 21: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 22: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 23: LATIN AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 24: LATIN AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 25: LATIN AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 26: LATIN AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 27: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 28: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 29: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 30: MIDDLE EAST AND AFRICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET MATURITY ANALYSIS

FIGURE 2: INDUSTRY COMPONENTS

FIGURE 3: GLOBAL COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)

FIGURE 4: GLOBAL COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)

FIGURE 5: GLOBAL COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)

FIGURE 6: GLOBAL COUGH SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)

FIGURE 7: GLOBAL COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)

FIGURE 8: GLOBAL COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)

FIGURE 9: GLOBAL COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)

FIGURE 10: GLOBAL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)

FIGURE 11: GLOBAL COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 12: GLOBAL COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 13: GLOBAL COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 14: GLOBAL COUGH SYRUP MARKET, BY REGIONAL OUTLOOK, 2022 & 2030 (IN %)

FIGURE 15: UNITED STATES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 16: CANADA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 17: UNITED KINGDOM COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 18: GERMANY COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 19: FRANCE COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 20: ITALY COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 21: SPAIN COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 22: REST OF EUROPE COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 23: CHINA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 24: JAPAN COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 25: INDIA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 26: SOUTH KOREA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 27: ASEAN COUNTRIES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 28: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 29: REST OF ASIA-PACIFIC COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 30: BRAZIL COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 31: MEXICO COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 32: REST OF LATIN AMERICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 33: UNITED ARAB EMIRATES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 34: TURKEY COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 35: SAUDI ARABIA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 36: SOUTH AFRICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 37: REST OF MIDDLE EAST & AFRICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying